in early-stage nsclc, give nivolumab before or after surgery?
Published 1 year ago • 147 plays • Length 4:49Download video MP4
Download video MP3
Similar videos
-
6:46
locally advanced lung cancer: no longer 'one size fits all'
-
11:30
asco 2021 lung recap: surgical outcomes & checkmate 816: nivolumab in early stage nsclc
-
1:31:34
tailoring targeted therapy: new directions for managing patients across the spectrum of nsclc
-
11:12
for nsclc neoadjuvant adjuvant or both
-
24:30
s1 episode 4: managing lung cancer with neoadjuvant and adjuvant therapy
-
26:18
s2 episode 3: standard of care in perioperative management of lung cancer: the past, present, and...
-
5:58
myth busting: do systemic therapies affect brain metastases?
-
5:19
lung cancer trials at asco 2022: what to expect
-
3:32
rapid recommendation update from asco for stage ib-iiia nsclc
-
1:49
a phase ii study of i-sabr in early or recurrent nsclc
-
7:03
neoadjuvant bests adjuvant therapy in lung cancer
-
5:36
treatment of early-stage nsclc
-
5:49
top 5 developments in lung cancer in 2021
-
1:01
dr. heymach on nivolumab for lung cancer
-
6:45
neoadjuvant nivolumab in nsclc
-
1:18
dr. joel neal on impact of pd-l1 tests on pembrolizumab, nivolumab efficacy in frontline nsclc
-
32:51
adjuvant therapy for early stage lung cancer – case based discussion for patient with stage 1b nsclc